---
title: "September 16–17 Investment News: Arcee $1B, Hang Ten $85M, BackOps $42M"
description: "Arcee’s Series B marks the open-weight lab above $1B (Fortune ≥$150M). Hang Ten added $53M seed (Xora) five weeks after $32M. Insight led BackOps $42M. Also: Delos $100M+, TypeSafe $40M, Complir $11M, Nomos €20M — plus Enhans and Manus briefs."
date: 2026-09-17T00:00:00.000Z
source: https://venturecapitaltracker.com/2026-september-16-17-investment-news-arcee-hang-ten-backops
---

# September 16–17 Investment News: Arcee $1B, Hang Ten $85M, BackOps $42M

> Arcee’s Series B marks the open-weight lab above $1B (Fortune ≥$150M). Hang Ten added $53M seed (Xora) five weeks after $32M. Insight led BackOps $42M. Also: Delos $100M+, TypeSafe $40M, Complir $11M, Nomos €20M — plus Enhans and Manus briefs.

September **16–17, 2026** closed a tape that mixes **open-weight unicorn marks**, **enterprise AI services seed velocity**, and **ops automation with production KPIs**. Deep dives below; briefs for deals we tracked but did not expand.

## Primary closes

| Date | Company | Amount | Stage | Lead / anchors | Memo |
| --- | --- | --- | --- | --- | --- |
| Sep 16 | [Arcee AI](/startup/arcee-ai) | **≥$150M** (Fortune); company **n/d** | Series B | Vista, Cambium, Emergence; **>$1B** mark | [Arcee memo](/2026-arcee-ai-150m-series-b-1b-vista-open-weight) |
| Sep 16 | [Hang Ten Systems](/startup/hang-ten-systems) | **$53M** ($85M total) | Seed extension | Xora (Temasek); Mayfield returning | [Hang Ten memo](/2026-hang-ten-53m-seed-extension-xora-temasek) |
| Sep 16 | [BackOps](/startup/backops) | **$42M** | Series B | [Insight Partners](/fund/insight-partners) | [BackOps memo](/2026-backops-42m-series-b-insight-supply-chain-ai) |
| Sep 16 | [TypeSafe AI](/startup/typesafe-ai) | **$40M** | Seed | DCVC; Forbes **$200M** mark | [TypeSafe memo](/2026-typesafe-ai-40m-seed-dcvc-jev) |
| Sep 15–16 | [Delos Data](/startup/delos-data) | **$100M+** | Unnamed | Matrix, Playground, Socratic, Capricorn, Matter, IAG | [Delos memo](/2026-delos-data-100m-inference-networking) |
| Sep 16 | [Complir](/startup/complir) | **$11M** | Seed | [General Catalyst](/fund/general-catalyst) | [Complir memo](/2026-complir-11m-seed-general-catalyst) |
| Sep 15 | [Nomos](/startup/nomos-energy) | **€20M (~$23M)** | Unlabeled | [Index Ventures](/fund/index-ventures) | [Nomos memo](/2026-nomos-20m-eur-index-ventures-energy) |

## Why this cluster matters

1. **Open weights got a U.S. billion-dollar print** — Arcee’s ~$20M Trinity training claim is the efficiency spine; amount still Fortune-sourced.
2. **Enterprise AI is splitting** — Hang Ten sells build-and-advise services to $10B+ logos; TypeSafe sells decision primitives for software; BackOps sells resolution outcomes in physical goods.
3. **Directory-linked funds showed up** — Insight (BackOps), GC (Complir), Index (Nomos). Vista/Cambium/Emergence/DCVC/Xora stay editorial-only.

## Briefs

### Enhans — ₩51.2B (~$37M) Series C

Seoul’s Enhans raised **₩51.2 billion (~$37 million)** Series C co-led by Timefolio and Stonebridge, bringing total funding to **₩81 billion**. POSCO Technology Investment, LG CNS, and Lotte Ventures joined as first-time strategic shareholders — affiliates of customer groups. Agent OS upgrade and overseas expansion are the stated uses ([Seoul Economic Daily](https://en.sedaily.com/technology/2026/09/17/enhans-raises-512-billion-won-in-series-c-for-enterprise-ai)). Covered here as a brief; USD lead used for US readers.

### Manus — ~$500M at ~$4B (talks)

Bloomberg reported Manus is set to roughly double to a **$4 billion** valuation on a planned **~$500 million** financing after Beijing ordered a split from Meta. Terms may still change; new investors unclear; existing backers include Tencent, HSG, ZhenFund ([Bloomberg](https://www.bloomberg.com/news/articles/2026-09-17/manus-eyes-4-billion-value-in-first-round-since-meta-breakup)). **Not a close.** Prior coverage: [/startup/manus-ai](/startup/manus-ai).

### Multiply Labs — $75M Series B (reported)

Dealroom and AI Insider reported a **$75 million** Series B with AstraZeneca Ventures, Lingotto, Legend Biotech, Strange Ventures, and returning Casdin, Lux, and Founders Fund. Multiply Labs’ public newsroom did not list a matching announcement at the time of writing — treat as **press-reported** until a company release confirms terms.

## Related September coverage

| Story | Where |
| --- | --- |
| Motive / Xapien tape | [Sep 10–12 index](/2026-september-10-12-investment-news-motive-xapien-physical-ai) |
| Full month | [September 2026 VC News](/2026-september-vc-news) |

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.